Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
A Practical, Clinically Driven Primer on Serotonin Receptors and Targeted Pharmacotherapy
Rakesh Jain, MD, MPH
Clinical ProfessorDepartment of PsychiatryTexas Tech Health Sciences CenterSchool of MedicineMidland, Texas
Outline of Today’s Presentation
History/ Discovery
of Serotonin
Role of Serotonin in Brain / Body
functioning
Interplay of Serotonin with other Neurotrans‐
mitters
Serotonin Receptor Pharma‐cology
Role of Various
Receptors in the
Serotonin Family
Clinical Implications
of our Learnings
Discovery of Serotonin: An “accidental” discovery in search of a hypertension agent
(“Sero” = serum; “Tonin” = vascular tone)
Booji L, et al. J Psychiatry Neurosci. 2015;40(1):5-18. Frodl T, et al. J Psychiatry Neurosci. 2015;40(5):296-305.
Dr. Maurice Rapport 1948
Early in the morning, he would go to the Clevelandslaughterhouse and collect eight 15 L buckets ofblood
Did this 60 times
Distilled this through a 5‐step process to finallyisolate Serotonin
900 L of serum obtained from 2 tons of bull’s blood,before Serotonin was discovered
Original vial of Serotonin
(still displayed at Cleveland Clinic medical museum)
A Timeline of Important Serotonin Events
SSRI = selective serotonin reuptake inhibitor.Booji L, et al. J Psychiatry Neurosci. 2015;40(1):5-18. Frodl T, et al. J Psychiatry Neurosci. 2015;40(5):296-305.
• 5-HT “low” in depression (1966)
• Antidepressants act via 5-HT (1963–1969)
• Discovery of many 5-HT receptors
• Development of 5-HT antagonists
• Identification/isolation of 5-HT (1948–1953)
• Discovery of 5-HT in brain (1954)
• Development of SSRIs
• 5-HT “low” in suicide (1976)
• Identification of 5-HT genetic polymorphisms
• “Low” 5-HT as vulnerability factor for stress-related disorders (stress-diathesis)
Reason Why Serotonin Matters: Serotonin is intimately involved in the
regulations of a vast number of human behaviors
Kumar JS, et al. Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112.
Mood
Modulate Aggression
Memory / Cognition
Sleep / Wakefulness
Neuroinflammation
Neuroendocrine Functioning Pain Modulation
Appetite / Satiety
Anxiety
Pleasure / Euphoria
Serotonin – A Life Story
Charnay Y, et al. Dialogues Clin Neurosci. 2010;12(4):471-487.
Steps:
Tryptophan is the precursor to serotonin.
Tryptophan is taken up by serotonergicneurons in restricted brain areas such as theraphe nucleus.
Once it enters the neurons, an enzymecalled tryptophan hydroxylase adds thehydroxyl group and produces 5-HTP (shortfor 5-hydroxytryptophan).
5-HTP is further decarboxylated by aromaticL-amino acid decarboxylase to produceserotonin.
Serotonin is then stored in synaptic vesiclesand docked at the nerve terminals, where itawaits an action potential.
Release of serotonin into the synaptic cleftactivates serotonergic receptors in the post-synaptic neurons.
Serotonin
Dorsal Raphe Cell
Dietary Tryptophan
Serotonin – Not Just in Humans: 5-HT is a “highly conserved” neurotransmitter and
Found in Multiple Places in Nature
Berger M, et al. Annu Rev Med. 2009;60:355-366. Badria FA. J Med Food. 2004;5(3):153-157.
Fungus
Found in all animal species
Plants
Fish species
Nuts / Seeds
Brain–Body distribution in humans
Serotonin
Serotonin in the Human Body, Where Does It Come From?
GI = gastrointestinal. Berger M, et al. Annu Rev Med. 2009;60:355-366.
90% of Human Serotonin, in the GI tract, the
Enterochromaffin cells are distributed widely in the
epithelium of the stomach, small intestine, and colon
5% of Human Serotonin comes from Myenteric Neurons, which are distributed in the muscle lining of the GI track
5% of Human Serotonin from the Brain – specifically the Dorsal Raphe, which then projects upwards to the
cortex, and downwards, to the cerebellum and spinal cord
Serotonin
Serotonin:Its Role in Human Emotion and Behavior
Charnay Y, et al. Dialogues Clin Neurosci. 2010;12(4):471-487.
Gut Motility Regulation
Mood Regulation
Regulating Insulin Secretion
Inflammation / Immune Regulation
Aggression / Dominance Modulation
Sleep–Wake Cycle
Regulation
Regulating Bone Metabolism
(through effects on Osteoblasts and Osteoclasts)
Serotonin
Cognition / Memory / Learning
Serotonin:Its Critical Role Even Prior to Birth
Volpicelli F, et al. Front Behav Neurosci. 2014;8:318.
Together with its function as neurotransmitter, 5-HT regulates neurite outgrowth, dendritic spine shape and density, growth
cone motility, and synapse formation during development
5-HT is synthesized early in embryonic development and its receptors are early expressed
The brain of the fetus receives Serotonin also from the placenta of the mother. The contribution of these maternal–placental–fetal interactions appears to be critical for brain circuit wiring and for long-term brain functions
Serotonin and Its Receptors are Involved in Neurogenesis in the Hippocampus
Klempin F, et al. Front Mol Neurosci. 2010;3:14.
BrdU = Bromodeoxyuridine is commonly used in the
detection of proliferating cells in living tissues
Serotonin Appears to be Involved at Nearly Every Stage of Neurodevelopment and Neuropathology
HPA = hypothalamic pituitary adrenal.Booji L, et al. J Psychiatry Neurosci. 2015;40(1):5-18. Frodl T, et al. J Psychiatry Neurosci. 2015;40(5):296-305.
Altered DNA Methylation Patterns
Altered brain development /
brain functioning
Altered Response to Stress, via1. HPA axis2. Autonomic
System3. Inflammatory
systemDevelopment of Psychopathology
Serotonin Receptor Numbers and Functioning
are Altered
Serotonin Pathways – Anatomic Connections with Multiple Regions in the Brain
Stahl SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Fourth Edition. New York: Cambridge University Press; 2013.
• Major origin in raphe nuclei of brain stem
• Project to forebrain• Median raphe nucleus innervates:
• Cingulate cortex• Septal nuclei• Hippocampus
• Dorsal raphe nucleus innervates:• Substantia nigra• Striatum• Amygdala• Nucleus accumbens
• Ascending pathways are implicated in the regulation of mood, feeding, sleep, and sexual behavior
• Descending projections appear to modulate spinal sensory and motor neurons
Raphe nuclei
PFC
ACC
Hy
T
S
A
H
C
C
Cerebral Cortex
NA
Serotonin Also Powerfully Modulates Other Neurotransmitter Systems and Inflammation
The Neural Circuitry of Monoamines is Extensively Interconnected
DA = dopamine; DRN = dorsal raphe nucleus; Glu = glutamate; LC = locus coeruleus; NE = norepinephrine; VTA = ventral tegmental area.El Mansari M, et al. CNS Neurosci Ther. 2010;16(3):e1-e17.
Glu Glu
Cortical pyramidal neurons
+
Β (+) α2A (─)
NENE
+
+
─
NE
NE
─α2
LCNE
─
DA
DA
D2/3 (─)
DA
DA
D2
α2
α1
VTA DA ─
5HT
─
D2 DRN5‐HT
+ indicates agonism or
stimulatory effect
─ indicates antagonism
or inhibitory effect
Serotonin: The “Thread” That Binds GABA and Glutamate in Health and Illness
GABA = γ-aminobutyric acid.Hurley LM, et al. Front Neural Circuits. 2012;6:58.
Serotonin and Immune Interactions in the Body
Kim K. Biomol Ther. 2012;20(6):506-512.
Serotonin Modulates and Impacts Glia Functioning – Astrocytes, Microglia, and Oligodendrocytes
Miyazaki I, et al. Curr Med Chem. 2016;23(7):686-700. Kolodziejczak M, et al. ACS Chem Neurosci.2015;6(7):1219-1230. Sankowski R, et al. Front Cell Neurosci. 2015;9:28.
A Quick Conversation about Receptor Affinity and Receptor Potency
In other words, let’s discuss these 2 concepts:
1. Ki Values
2. IC50 Values
Exploring the Concept of IC50 and Ki values
Copeland RA, et al. Bioorganic & Medicinal Chemistry Letters. 1995;5(17):1947-1952.
What is IC50?
• This quantitative measure indicates how much of a drug isneeded to inhibit a given biological process by half.According to the FDA, IC50 represents the concentration ofa drug that is required for 50% inhibition in vitro
What is Ki value?
• Ki is the binding affinity of the inhibitor. It’s also called theEquilibrium Constant
• Calculation is done as follows:
Ki =(Conc Ligand) X (Conc Receptor)
(Conc of Ligand Receptor Complex)
Why is an Understanding of Both Affinity and Potency Important?
IA = intrinsic activity; SERT = serotonin transporter; VOR = vortioxetine.Sanchez C, et al. Pharmacol Ther. 2015;145:43-57.
So, based on Ki values – the order of affinity is SERT > 3 > 1 > 7 > 1B > 1D
So, based on IC50 values – the order of potency is SERT > 3 > 1B > 1A > 1D > 7
Let’s illustrate how these 2 can be different in a single molecule – vortioxetine as an example
Now you see why knowing both Affinity and Potency for receptors is important!
Agonism, Partial Agonism, Antagonism and Inverse Agonism – All are Important Concepts for Us
Clinicians to Fully Understand
Hoyer D, et al. Trends Pharmacol Sci. 1993;14(7):270-275. Gershon MD, et al. Gastroenterology. 2007;132(1):397-414.
Dose response curves of a full agonist, partial agonist, neutral antagonist, and inverse agonist
Another Way to Look at Agonism, Antagonism, Inverse Agonism at a Receptor
Hoyer D, et al. Trends Pharmacol Sci. 1993;14(7):270-275. Gershon MD, et al. Gastroenterology. 2007;132(1):397-414.
Serotonin Receptors
A quick primer for the busy, modern clinician
Why We Clinicians Need to Know More about Serotonin and Its Receptor Pharmacology
This enhanced knowledge could
diminish side‐effect burden
This enhanced knowledge could
increase therapeutic benefit
Caution: This is exciting, emerging science where much work still needs to be done
Why We Must be Interested in Receptor Pharmacology of the Serotonin System – Many Tools, Our Medications,
Work Through Serotonin Receptors
LSD = lysergic acid diethylamide; MAOI = monoamine oxidase inhibitor.Meltzer HY, et al. Curr Opin Pharmacol. 2011;11(1):59-67. Naughton M, et al. Hum Psychopharmacol. 2000;15(6):397-415.
Serotonin Acts Through Its “Messengers”: The 7 Members of Serotonin Receptor Family (5-HT1, 2, 3, 4, 5, 6, 7)
Kumar JS, et al. Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112.
Serotonin Receptors:A Total of 14 Total Family Members
Kumar JS, et al. Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112.
Serotonin Receptors and Their Regional Distribution
Brichta L, et al. Trends Neurosci. 2013;36(9):543-554.
Cerebral cortex1A, 2A, 1B, 2C, 1E, 5, 7
S1B, 1D, 1E, 2A, 2C, 3, 4, 6
NA1B, 1D, 2A, 2C, 4, 6
VTA2C
SN2C
RN1A, 1B, 1D
H1A, 1B, 2A, 2C, 3, 6, 7
Charnay Y, et al. Dialogues Clin Neurosci. 2010;12(4):471-487.
5‐HT receptors in the human brain: distribution, putative functions, and related pathologies. Pre‐RNA *splicing and °editing variants.
X = dorsal motor n of the vagus nerve;
CAN = accumbens n;
Amy = amygdala;
Cc = corpus callosum;
Ce = cerebellum;
Cpu= caudate‐putamen;
Cx = cortex;
DRN = dorsal raphe n;
Fcx = frontal cortex;
Hip = hippocampus;
Hyp = hypothalamus;
LS = lateral septum;
MRN = n, nucleus;
SN = subtantia nigra;
Tha = thalamus;
VTA = ventral tegmental area.
5-HT1A – Why It Matters and How 5-HT1A Agonists / Partial Agonists Can Augment Antidepressant Effect
SNRI = serotonin-norepinephrine reuptake inhibitor.Celada P, et al. CNS Drugs. 2013;27(9):703-716. Chilmonczyk Z, et al. Int J Mol Sci. 2015;16(8):18474-18506. Stahl SM, et al. Curr Drug Targets. 2013;14(5):578-585.
Normal Serotonergic Neurotransmission
SSRI/SNRI Effects onSerotonergic Neurotransmission
5‐HT1A upregulation may lead to tachyphylaxis of antidepressant activity
5‐HT1A agonists/partial agonists can therefore augment antidepressants
How Atypical Antipsychotics May Putatively Work:The Emerging Role of Serotonin 5-HT2A and 5-HT1AReceptors in Facilitating an Antidepressant Effect
PFC = prefrontal cortex.Chilmonczyk Z, et al. Int J Mol Sci. 2015;16(8):18474-18506. Celada P, et al. CNS Drugs. 2013;27(9):703-716.
Serotonin 5-HT1A and 5-HT2A and GlutaminergicPyramidal Cells – Critical Importance of Serotonin’s
Control and Regulatory Properties
Celada P, et al. Front Integr Neurosci. 2013;7:25.
Serotonin plays a regularly role in other neurotransmitter release besides Glutamate.The others include:AcetylcholineDopamineGABAHistamine
5‐HT1A and 5‐HT2A receptors are key players and exert opposite effects on the activity of pyramidal neurons in the medial prefrontal cortex (mPFC)
5-HT1A and 5-HT1B – Important Self Regulators: The Need for Agonistic Activity at These Receptors
Artigas F. Pharmacol Ther. 2013;137(1):119-131. Lutz PE. J Neurophysiol. 2013;109(9):2245-2249. El Mansari M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):362-373.
5‐HT1A and 1B are regulatory of serotonin functioning
Chronic SSRI treatment was shown to induce desensitization and reduced expression of 5‐HT1Bautoreceptors, likely contributing to increased serotonergic tone during SSRI exposure
The 5‐HT1B receptor is another Gi‐coupled receptor, expressed both as an auto‐ and hetero‐receptor. In contrast to the somato‐dendritic 5‐HT1AR autoreceptor, the 5‐HT1BR is localized in axon
terminals of 5‐HT neurons thereby controlling 5‐HT release in projection regions
Another Serotonin Receptor of Interest – 5-HT7
CNS = central nervous system. Volpicelli F, et al. Front Behav Neurosci. 2014;8:318.
Ishibashi T, et al. J Pharmacol Exp. 2010;334(1):171-181.
Serotonin 5-HT7 Functions:
- Cloned for 3 independent laboratories in 1993- Important in normal embryonic brain
development - Expressed centrally and peripherally- In the CNS, the receptor is expressed in the
diencephalon, forebrain, and in the Purkinje neurons of the cerebellum
- Involved with circadian rhythms, sleep-wake cycle, thermoregulation, nociception, cognition such as learning and memory processes
- Thought to be involved in disorders such as anxiety, depression, epilepsy, impulsivity, migraine, etc
Evidence: An atypical with significant 5‐HT7 antagonistic activity (lurasidone) ameliorateslearning and memory deficits in animal model of schizophrenia and induces anantidepressant‐like response in animal models for depression and anxiety. Interestingly,these pharmacologic actions of lurasidone are mediated, at least partially, by 5‐HT7R
Many Drugs of Abuse / Misuse (and Some Incredible, Potential Clinical Benefits Too!) Exert Their Effects
Through the Serotonergic System – Focus on 5-HT2A
Carhart-Harris RL, et al. Psychol Med. 2016;46(7):1379-1390.
Atypical Anti‐psychotics
Psychedelics/ Hallucinogens
An Example of How a Side Effect Could be Diminished by Knowing More about Serotonin Receptor Pharmacology
Serotonin 5-HT2C Receptor and Body Weight
Meltzer HY, et al. J Clin Invest. 2013;123(12):4986-4991. Matsui-Sakata A, et al. Drug MetabPharmacokinet. 2005;20(5):368-378.
Multiple antipsychotics, some antidepressants
Lorcaserin
Serotonin Receptors: Weight Gain and Diabetes Risk
Matsui-Sakata A, et al. Drug Metab Pharmacokinet. 2005;20(5):368-378.
The correlation between receptor occupancies and the risks of adverse reactions (weight gain and morbidity rate of type 2 diabetes mellitus)
Receptor
Spearman Rank Correlation
Weight gain(Index l)
Morbidity rate of type 2 diabetes mellitus
rs rs
α1 Adrenergic 0.50 0.60
α2 Adrenergic 0.41 0.70
Dopamine D2 0.14 -0.10
Histamine H1 0.81 0.90
Muscarinic ACh 0.83 0.90
Serotonin 5-HT1A 0.26 0.70
Serotonin 5-HT2A 0.49 0.70
Serotonin 5-HT2c 0.53 0.90
Therapeutic Potential of Serotonin Receptor Polymorphism Testing
Will It be the Wave of the Future?
Kato M, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2009;29(1):23-31.
• Rs6295C/G SNP in the 5‐HT1A gene (HTR1A) hasbeen found to affect the expression and functionof HTR1A
• Study examined the possible association of apanel of markers in strong linkage disequilibriumof HTR1A with SSRI/SNRI response in 137Japanese major depression participants followedfor 6 weeks
• A significant association of better response toantidepressant in rs10042486C/C (P < .0001),rs6295G/G (P < .0001), and rs1364043T/T (P =.018) genotype carriers, independently fromclinical variables
Another Example of Emerging Pharmacogenetics with Serotonin Receptors
Focus on 5-HT2A Receptor Polymorphism
BDNF = brain-derived neurotrophic factor; SNP = single nucleotide polymorphism.
Kautzky A, et al. Eur Neuropsychopharmacol. 2015;26(4):441-453.
• Findings from a 225‐patient, decade‐long study from the European Group for the study of Resistant Depression
• When 12 SNPs from 5‐HT2A, COMT, PPP3CC, and BDNF are combined with 8 clinical variables, this correctly predicted 25% of responders
Summarizing Thoughts on Serotonin Receptor Polymorphism
Kautzky A, et al. Eur Neuropsychopharmacol. 2015;26(4):441-453.
• This is an emerging, not settled scientific area of investigation
• Individual SNPs have low effect
• But, when using multiple SNPs, and using interactive models, statistically significant predictive models are emerging
• Stay tuned! Cautious optimism is warranted
Serotonin Receptors – Location and Function: Both are Important Elements of Important Clinical Knowledge
Meltzer HY, et al. J Clin Invest. 2013;123(12):4986-4991.
Members of the 5‐HT2 familydisplays distinct brain and tissuedistributions. The 5‐HT2A receptoris enriched in pyramidal neuronsin layer V of the cerebral cortex,where it mediates the actions ofpimavanserin and other atypicalantipsychotic drugs. The 5‐HT2Breceptor is enriched in interstitialcells of the heart valves, where itmediates the valvulopathic actionsof certain drugs like fenfluramine.The 5‐HT2C receptor is enriched inthe hypothalamus, among other areas,particularly in nuclei engaged inregulating feeding behavior, henceit’s a target for lorcaserin.
“Targeted”, Selective Serotonin Receptor-Based Drug Development2 Recent, FDA Approved Examples
Meltzer HY, et al. J Clin Invest. 2013;123(12):4986-4991.
1. Lorcaserin
FDA indication: Weight Loss
Mechanism of action: 5-HT2C
Agonist
2. Pimavanserin
FDA indication: Psychosis in Parkinson’s disease
Mechanism of action: 5-HT2A
antagonist (no dopamine effects)
FDA Labels are Evolving, and Have More Receptor Binding Profile Information
US Food and Drug Administration. www.accessdata.fda.gov/scripts/cder/drugsatfda/.
In Conclusion
So, what are we clinicians to take home from our enhanced knowledge base on Serotonin and its receptors?
Conclusion: Part 1 of 3
• Serotonin has evolved with us humans over amillennia and play a hugely diverse role in mind–body functioning
• We humans, as early as in utero as fetuses, needoptimized Serotonin functioning
• Mental health and mental illnesses are intricatelytied with serotonin and its receptors’ functioning(or dysfunction)
Conclusion: Part 2 of 3
• Drug development is showing a trend towardsselective targeting of serotonin receptors, with thegoal to improve efficacy and decrease side effects
• FDA labels increasingly point our serotoninreceptor profiles in the package inserts (section12.2 – “Pharmacodynamics”)
Conclusion: Part 3 of 3
• Pharmacogenetics are increasingly (though notyet conclusively) pointing to the importance ofserotonin receptor genetic polymorphism as partof a reason for medication response (or lack thereof)
• We clinicians can increasingly use our enhancedknowledge base to offer treatments that aregeared towards increasing our clinical output (abalance between safety/tolerability and efficacy)